Call the Department of Gastroenterology: 617-726-2426
Explore This Treatment
Overview
This year over 50,000 men and women in the U.S. will die from colon cancer. And many could have been saved. When colon cancer is detected early, there is a 90% survival rate. When it's not, that number is less than 50%. Starting at age 50, you should have a colonoscopy at least once every ten years to screen for polyps and cancer. Colon cancer can be beaten. Prevention and early detection are your best weapons.
We offer the most advanced colon cancer screenings and treatments available. Our world-renowned specialists can provide the comprehensive care and peace of mind you'll only find at one of the world's leading hospitals.
Talk to your doctor about scheduling your colorectal cancer screening at Massachusetts General Hospital. Then call (617) 726-2426 or request an appointment online.
Please visit our doctors page for a list of our gastroenterologists.
Other options for Colorectal cancer screening
The COVID-19 pandemic has brought the need for individualized decision-making for colorectal cancer screening. Understanding the different CRC screening options, including home-based stool tests and colonoscopy, depends on the individual risk of colon cancer and the patient’s preferences. Patients can explore and compare the benefits, harms, and risks of each option as they make an informed decision about what matters most to them.
The below sheet describes three screening options that are reasonable for most people: schedule a colonoscopy, have a stool-based test, or delay your colonoscopy for a year.
Colorectal Cancer Screening Shared-Decision Worksheet English | Español
Colonoscopy Risks and Benefits
A colonoscopy is a procedure that involves an examination of the entire colon and requires bowel preparation and sedation. Watch this video to learn about the purpose and benefits of the exam, how the colonoscopy procedure is performed, and the potential risks and complications.
1
of
1
Endoscopic Procedures During COVID-19
Peter Carolan, MD, clinical chief of the Massachusetts General Hospital Division of Gastroenterology, and Norman Nishioka, MD, director of Endoscopy, discuss the safety measures that have been implemented at Mass General and explain the importance of getting the care you need without delay.
Mass General Cancer Center investigators found that nine percent of esophageal adenocarcinoma patients harbor mutations in cancer-predisposing genes, shedding light on the causes of progression to the disease and new possibilities for screening and treatment.
A recent study found that adults with HIV who took a daily statin reduced their risk of major cardiovascular events (MACE) by 35% and their risk of MACE or premature death by 21%.